Exploratory study of the effect on gut microbiota by ingestion of oligosaccharide

UMIN ID: UMIN000056780

Registered date:11/02/2025

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Healthy adults
• Date of first enrollment: 2025/02/11
• Target sample size: 57
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): Oral ingestion of oligosaccharide for 2 weeks

Outcome(s)

• Primary Outcome: Occupancy rate of each gut microbiota species in feces

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1. Those who have participated in a study involving another intervention during the month prior to screening or who plan to participate in a study involving another intervention during the period between screening and the end of the intake period 2. Those who have a history of gastric or lower gastrointestinal tract surgery excluding hemorrhoids 3. Those who have a barium stomach X-ray, small or large intestine endoscopy, or bowel cleansing at a clinic or at home during the month prior to screening, or those who are scheduled to have these procedures during this study 4. Who have taken, ingested, or used drugs that may affect the study at least once a week during the month prior to screening, or who plan to take, ingest, or use these drugs at least once during the study 5. Those who plan to travel abroad, travel for more than one week, or go on a business trip during the period from one week prior to the intake period to the end of the intake period 6. Those who have food allergies 7. Those who are pregnant or breastfeeding 8. Subjects judged as unsuitable for the study by the principal investigator or research physician for other reasons

Related Information

• Primary Sponsor: Meiji Holdings Co., Ltd.
• Source(s) of Monetary Support: Meiji Holdings Co., Ltd.